These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28731446)

  • 1. Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life.
    Sinclair LI; Love S
    J Alzheimers Dis; 2017; 59(3):1123-1137. PubMed ID: 28731446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synaptic protein levels altered in vascular dementia.
    Sinclair LI; Tayler HM; Love S
    Neuropathol Appl Neurobiol; 2015 Jun; 41(4):533-43. PubMed ID: 25559750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic loss in schizophrenia: a meta-analysis and systematic review of synaptic protein and mRNA measures.
    Osimo EF; Beck K; Reis Marques T; Howes OD
    Mol Psychiatry; 2019 Apr; 24(4):549-561. PubMed ID: 29511299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOE genotype alters glial activation and loss of synaptic markers in mice.
    Zhu Y; Nwabuisi-Heath E; Dumanis SB; Tai LM; Yu C; Rebeck GW; LaDu MJ
    Glia; 2012 Apr; 60(4):559-69. PubMed ID: 22228589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective loss of synaptic proteins in Alzheimer's disease: evidence for an increased severity with APOE varepsilon4.
    Tannenberg RK; Scott HL; Tannenberg AE; Dodd PR
    Neurochem Int; 2006 Dec; 49(7):631-9. PubMed ID: 16814428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Segmented Linear Mixed Model Analysis Reveals Association of the APOEɛ4 Allele with Faster Rate of Alzheimer's Disease Dementia Progression.
    Chen XR; Shao Y; Sadowski MJ;
    J Alzheimers Dis; 2021; 82(3):921-937. PubMed ID: 34120907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic changes in frontotemporal lobar degeneration: correlation with MAPT haplotype and APOE genotype.
    Connelly SJ; Mukaetova-Ladinska EB; Abdul-All Z; Alves da Silva J; Brayne C; Honer WG; Mann DM
    Neuropathol Appl Neurobiol; 2011 Jun; 37(4):366-80. PubMed ID: 21073671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERβ and ApoE isoforms interact to regulate BDNF-5-HT
    Chhibber A; Zhao L
    Alzheimers Res Ther; 2017 Sep; 9(1):79. PubMed ID: 28934977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apolipoprotein E4 domain interaction: synaptic and cognitive deficits in mice.
    Zhong N; Scearce-Levie K; Ramaswamy G; Weisgraber KH
    Alzheimers Dement; 2008 May; 4(3):179-92. PubMed ID: 18631967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of synaptophysin and synaptosomal-associated protein 25-kDa (SNAP-25) in elderly Down syndrome individuals.
    Downes EC; Robson J; Grailly E; Abdel-All Z; Xuereb J; Brayne C; Holland A; Honer WG; Mukaetova-Ladinska EB
    Neuropathol Appl Neurobiol; 2008 Feb; 34(1):12-22. PubMed ID: 18005332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progressive accumulation of amyloid-beta oligomers in Alzheimer's disease and in amyloid precursor protein transgenic mice is accompanied by selective alterations in synaptic scaffold proteins.
    Pham E; Crews L; Ubhi K; Hansen L; Adame A; Cartier A; Salmon D; Galasko D; Michael S; Savas JN; Yates JR; Glabe C; Masliah E
    FEBS J; 2010 Jul; 277(14):3051-67. PubMed ID: 20573181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The APOE ɛ4/ɛ4 genotype potentiates vascular fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients.
    Hultman K; Strickland S; Norris EH
    J Cereb Blood Flow Metab; 2013 Aug; 33(8):1251-8. PubMed ID: 23652625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 37 Years of Body Mass Index and Dementia: Effect Modification by the APOE Genotype: Observations from the Prospective Population Study of Women in Gothenburg, Sweden.
    Bäckman K; Joas E; Waern M; Östling S; Guo X; Blennow K; Skoog I; Gustafson DR
    J Alzheimers Dis; 2015; 48(4):1119-27. PubMed ID: 26402098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperglycemia induced the Alzheimer's proteins and promoted loss of synaptic proteins in advanced-age female Goto-Kakizaki (GK) rats.
    Pintana H; Apaijai N; Kerdphoo S; Pratchayasakul W; Sripetchwandee J; Suntornsaratoon P; Charoenphandhu N; Chattipakorn N; Chattipakorn SC
    Neurosci Lett; 2017 Aug; 655():41-45. PubMed ID: 28652187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. APP depletion alters selective pre- and post-synaptic proteins.
    Martinsson I; Capetillo-Zarate E; Faideau M; Willén K; Esteras N; Frykman S; Tjernberg LO; Gouras GK
    Mol Cell Neurosci; 2019 Mar; 95():86-95. PubMed ID: 30763689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher prevalence of cerebral white matter hyperintensities in homozygous APOE-ɛ4 allele carriers aged 45-75: Results from the ALFA study.
    Rojas S; Brugulat-Serrat A; Bargalló N; Minguillón C; Tucholka A; Falcon C; Carvalho A; Morán S; Esteller M; Gramunt N; Fauria K; Camí J; Molinuevo JL; Gispert JD
    J Cereb Blood Flow Metab; 2018 Feb; 38(2):250-261. PubMed ID: 28492093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E4 inhibits autophagy gene products through direct, specific binding to CLEAR motifs.
    Parcon PA; Balasubramaniam M; Ayyadevara S; Jones RA; Liu L; Shmookler Reis RJ; Barger SW; Mrak RE; Griffin WST
    Alzheimers Dement; 2018 Feb; 14(2):230-242. PubMed ID: 28945989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative Survival Advantages in Young Apolipoprotein ɛ4 Carriers are Associated with Increased Neural Stress.
    Smith CJ; Ashford JW; Perfetti TA
    J Alzheimers Dis; 2019; 68(3):885-923. PubMed ID: 30814349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anterior Cingulate Structure and Perfusion is Associated with Cerebrospinal Fluid Tau among Cognitively Normal Older Adult APOEɛ4 Carriers.
    Hays CC; Zlatar ZZ; Meloy MJ; Osuna J; Liu TT; Galasko DR; Wierenga CE
    J Alzheimers Dis; 2020; 73(1):87-101. PubMed ID: 31743999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Apolipoprotein E ɛ4 Carrier Status on Cognitive Response to Acetylcholinesterase Inhibitors in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Cheng YC; Huang YC; Liu HC
    Dement Geriatr Cogn Disord; 2018; 45(5-6):335-352. PubMed ID: 30041236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.